Stage-specific prognostic biomarkers in melanoma

Oncotarget
Yabin ChengYouwen Zhou

Abstract

The melanoma staging system proposed by the American Joint Committee on Cancer (AJCC) (which classifies melanoma patients into four clinical stages) is currently the most widely used tool for melanoma prognostication, and clinical management decision making by clinicians. However, multiple studies have shown that melanomas within specific AJCC Stages can exhibit varying progression and clinical outcomes. Thus, additional information, such as that provided by biomarkers is needed to assist in identifying the patients at risk of disease progression. Having previously found six independent prognostic biomarkers in melanoma, including BRAF, MMP2, p27, Dicer, Fbw7 and Tip60, our group has gone on to investigate if these markers are useful in risk stratification of melanoma patients in individual AJCC stages. First, we performed Kaplan-Meier survival and Cox proportional multivariate analyses comparing prognostication power of these markers in 254 melanoma patients for whom the expression levels were known, identifying the best performing markers as candidates for stage-specific melanoma markers. We then verified the results by incorporating an additional independent cohort (87 patients) and in a combined cohort (341 patients). Our d...Continue Reading

References

Aug 22, 2000·The Journal of Investigative Dermatology·U B HofmannD J Ruiter
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Oct 26, 2002·Cancer Cell·Alan N Houghton, David Polsky
Jun 6, 2003·Oncogene·Heng WuFrank G Haluska
Jan 8, 2004·The Journal of Investigative Dermatology·Amir S YazdiChristian A Sander
Apr 3, 2004·Cancer Research·Claudia WellbrockRichard Marais
Sep 24, 2004·Physiological Reviews·Andrzej SlominskiJacobo Wortsman
Oct 7, 2004·Cancer Research·Jill M StahlGavin P Robertson
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Phyllis A GimottyDupont Guerry
Jan 21, 2006·Cancer Research·Klaus P HoeflichSomasekar Seshagiri
May 9, 2006·Cancer Metastasis Reviews·Elena I Deryugina, James P Quigley
Aug 29, 2007·Oncogene·C MichaloglouD S Peeper
Jan 12, 2008·Human Pathology·Anne H VäisänenTaina Turpeenniemi-Hujanen
Mar 21, 2008·Nature Reviews. Cancer·Isabel M ChuJoyce M Slingerland
Mar 26, 2009·Journal of the National Cancer Institute·Bonnie E Gould RothbergDavid L Rimm
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H GogasR Dummer
Nov 6, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohammed Kashani-SabetRichard W Sagebiel
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Jun 18, 2010·The Journal of Investigative Dermatology·Bonnie E Gould Rothberg, David L Rimm
Oct 23, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seth A WanderJoyce M Slingerland
Apr 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Augustinus P T van der PloegAlexander M M Eggermont
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Aug 11, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Guangdi ChenGang Li
Aug 13, 2011·Pigment Cell & Melanoma Research·Andrzej SlominskiJohn Pawelek
Sep 2, 2011·Histopathology·David A MooreGerald S Saldanha
Jun 7, 2012·Cellular Oncology (Dordrecht)·Anand RotteGang Li
Jun 8, 2012·The Journal of Investigative Dermatology·Guangdi ChenGang Li
Oct 3, 2012·The American Journal of Surgical Pathology·Georgina V LongRichard A Scolyer
Oct 13, 2012·Nature Reviews. Drug Discovery·Gideon BollagPeter Hirth
Feb 6, 2013·The Journal of Investigative Dermatology·Yabin ChengGang Li
Apr 2, 2014·Mayo Clinic Proceedings·Andrzej T Slominski, J Andrew Carlson
Jul 9, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea MaurichiMario Santinami

❮ Previous
Next ❯

Citations

Dec 2, 2015·Expert Review of Molecular Diagnostics·Mona FothWilliam M Gallagher
Jan 7, 2020·Cancer Biomarkers : Section a of Disease Markers·Qi WanZhichong Wang
Jun 12, 2020·Journal of Surgical Oncology·Mihir M ShahDarren R Carpizo
Nov 14, 2018·Statistics in Medicine·Yifan SunShuangge Ma
Dec 12, 2017·Proteomics. Clinical Applications·Erin K SykesRichard I Christopherson
Dec 3, 2020·Cells·Pasquale PisapiaGiancarlo Troncone

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Software Mentioned

SPSS
tile

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved